IL1F10 and Alzheimer disease: Additionally, although we observed that subcutaneous injection of rmIL-38 can promote DNFB-induced AD symptoms, due to our current experiment's designs and laboratory limitations, we did not construct IL-38 overexpressing transgenic mice to investigate whether overexpression of IL-38 in skin can spontaneously induce AD-like symptoms and corresponding verification.